Author:
Goonewardene Sanchia S.,Persad Raj,Motiwala Hanif,Albala David
Publisher
Springer International Publishing
Reference65 articles.
1. Abdollahzadeh P, Madani SH, Khazaei S, Sajadimajd S, Izadi B, Najafi F. Association between human papillomavirus and transitional cell carcinoma of the bladder. Urol J. 2017;14(6):5047–50.
2. Allione A, Pardini B, Viberti C, Giribaldi G, Turini S, Di Gaetano C, Guarrera S, Cordero F, Oderda M, Allasia M, Gontero P, Sacerdote C, Vineis P, Matullo G. MMP23B expression and protein levels in blood and urine are associated with bladder cancer. Carcinogenesis. 2018.
3. Bangma CH, Loeb S, Busstra M, Zhu X, El Bouazzaoui S, Refos J, Van Der Keur KA, Tjin S, Franken CG, van Leenders GJ, Zwarthoff EC, Roobol MJ. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers. Eur Urol. 2013;64(1):41–7.
4. Behrens A, Stehle T, Gross S, Aach T. Local and global panoramic imaging for fluorescence bladder endoscopy. In: Conference Proceedings of the IEEE Engineering in Medicine and Biology Society. 2009. p. 6990–3.
5. Bonberg N, Taeger D, Gawrych K, Johnen G, Banek S, Schwentner C, Sievert KD, Wellhäußer H, Kluckert M, Leng G, Nasterlack M, Stenzl A, Behrens T, Brüning T, Pesch B; UroScreen Study Group. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study. BJU Int. 2013;112(4):E372–82.